Research we do
Knowledge of the molecular mechanisms underlying life and death decisions in (patho)physiological contexts is key for both the identification of biomarkers and the development of novel therapies to combat degenerative diseases and cancer. At our Institute we bridge the gap between basic science and translation through the identification and pharmacological targeting of key nodes in cell death and necro-inflammatory processes.